| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37b416a8c0d2b0f1c3d6026d932027af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb5c130520703bd9cca773d0b9ae9abd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3e1ef44b2c98df871f9b2f38b293941 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| filingDate |
2007-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c7fe1241bcfbe3c32ba2aa151a807c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_446c65da86082e3bc90a3ec2d452d08e |
| publicationDate |
2007-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007113683-A2 |
| titleOfInvention |
Modulation of tc10 function and method of treating glucose metabolic disorders |
| abstract |
A method is provided for increasing glucose uptake of a cell, comprising modulating activity of Ariadne-1. Also provided is a method of treating hyperglycemia or a disorder related to hyperglycemia in a patient, comprising administering to the patient a modulator of Ariadne-1 activity in a cell of the patient, wherein the cell is associated with the hyperglycemia or the disorder related to hyperglycemia. |
| priorityDate |
2006-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |